Turning Paid Pilots into Commercialization Agreement

By: Dylan Sikes – AllPennyStocks.com News

Thursday, May 12, 2022

With a focus on providing Turkish caregivers state of the art solutions and services for teledermatiology, this company works close with the medical field to provide early detections while reducing medical costs.

MedX Health Corp. (TSXV: MDX) has signed a commercial distribution agreement with Makromed/Arhan Global A.Ş after the conclusion of a successful paid pilot project. The pilot allowed Makromed to better understand the patient pathway and assess the addressable market size.

Results from the pilot concluded with the MedX DermSecure Screening Platform receiving a very high level of acceptance amongst Turkish health care professionals, including dermatologists and oncologists. Per the company’s press release, Makromed has committed to an initial 60-unit order for 2022, with an immediate order of 40 units and an option for 20 more units to be confirmed by October 2022.

Shares were up over 8 percent in early afternoon trade.

Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.